Ask AI
ProCE Banner Activity

Abnormal Involuntary Movement Scale (AIMS) Examination and Scoring Guide

PDF

Download this editable PDF outlining the Abnormal Involuntary Movement Scale (AIMS) for clinical use in assessing patients with potential symptoms of tardive dyskinesia.

Released: June 17, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Teva.

Teva

Target Audience

This activity is intended for Nurse Practitioners, Nurses, Physician Assistants, and others involved in the care of patients with tardive dyskinesia who may benefit from this education.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Implement proactive risk-stratification and monitoring strategies to identify and counsel older adults or long-term antipsychotic-treated patients at heightened risk for TD

  • Apply validated screening tools and structured assessment protocols within routine clinical workflows to ensure timely detection, documentation, and follow-up of TD across diverse care settings

  • Evaluate the efficacy, safety, and tolerability profiles of FDA-approved VMAT2 inhibitors to individualize pharmacologic management of TD in older adults and special populations